Counterfeit medicines in legitimate supply chains SDCP &PSI Study
Analysis of reports over a five year period – from 2005 to 2010 – indicates that counterfeit medicines increased by 122% while diversion and theft
increased by 66%.
Improvements in surveillance, including detection of security breaches, data
collection, analysis, and dissemination are urgently needed to address the public
health need to combat the global counterfeit medicines trade.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.Learn more
Media ContactAbigail Jones email@example.com